cvd

  1. madman

    Impact of TRT on Adverse Cardiovascular Events in Men with Low Testostosterone: Evaluation of Physiological and Supraphysiological T Levels

    https://academic.oup.com/jsm/article/21/Supplement_1/qdae001.084/7600775 Abstract Introduction Sustained treatment with elevated levels of exogenous testosterone (T) has been linked to various adverse events, particularly concerning cardiovascular risks. However, there is currently a lack of...
  2. madman

    Evaluation of the Male with Erectile Dysfunction

    37.1 Introduction The evaluation of the male who presents with erectile dysfunction (ED) can be one the most impactful visits in the long-term health of the patient. As illustrated in this chapter, ED has a number of important implications for overall men’s health. ED may be the only symptom...
  3. madman

    Molecular Biology and Physiology of Erectile Function and Dysfunction

    36.1 Introduction Erectile dysfunction (ED) refers to the inability to achieve or maintain an erection for satisfactory sexual performance. It is highly prevalent among aging men and can have a significant impact on quality of life and interpersonal relationships [1]. It was estimated in 2000...
  4. madman

    Menopause and Estrogen

    On this episode, Dr. Sadaf Lodhi is joined by renowned Medical Oncologist, Dr. Avrum Bluming to discuss everything you need to know about menopause and estrogen. From the need for sex-specific research in medicine to common misconceptions, this episode dives deep into the significant steps being...
  5. madman

    Estrogen and cardiovascular disease in women

    Abstract A large body of scientific research accumulated over the past twenty years documents the cardiovascular (CV) benefits of estradiol (E2) and progesterone (P4) in reproductive-aged women. In contrast, accelerated development of CV disease (CVD) occurs in the absence of ovarian-produced...
  6. madman

    The Most Exciting Time for Testosterone - TRAVERSE Results 4 Studies

    https://www.medscape.com/viewarticle/999636?form=fpf Rachel S. Rubin, MD: I am Dr Rachel Rubin, urologist and sexual medicine specialist in the Washington, DC, area. I am so blessed to have with me one of my favorite sexual medicine doctors on earth, Dr Mo Khera, professor of urology at...
  7. madman

    Is TRT safe in men who are at high risk for cardiovascular disease?

    Dr. Khera breaking it down! Is testosterone replacement therapy safe in men who are at high risk for cardiovascular disease? Ask a Sexpert! Dr. Mohit Khera explains this topic in our latest edition of this video series.
  8. madman

    PDE5 inhibitors (Cialis, Viagra, etc) and cardiac health: Princeton IV consensus guidelines:

    Been waiting on this one. Damn, that is deep! Abstract Background In 1999, 1 year after the approval of the first oral phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction(ED), the first Princeton Consensus Conference was held to address the clinical...
  9. madman

    The Safety Of Systemic Menopausal Hormone Therapy

  10. madman

    Associations Of T, DHT, Estradiol, And SHBG With All-cause And Cardiovascular Mortality

    Studies examining associations of circulating sex steroids with mortality risk in men show inconsistent results for testosterone (T), with limited data for dihydrotestosterone (DHT) and estradiol (E2). We aimed to clarify associations of sex steroids, sex hormone-binding globulin (SHBG), and...
  11. madman

    Clitoris color Doppler ultrasound - Female Sexual Dysfunction

    Clitoral Doppler ultrasound (CDU) is a noninvasive and easily applicable test used to assess the vascular patency and perfusion of clitoral arteries by measuring the rate of change in blood flow. Among hemodynamic parameters assessed during CDU, the pulsatility index (PI) is proposed to reflect...
  12. madman

    TRT on cardiovascular outcomes in hypogonadal men

    Abstract Objective To investigate the impact of testosterone replacement therapy (TRT) on cardiovascular outcomes in hypogonadal men. Methods A meta-analysis of 26 randomized controlled trials involving 10 941 participants was conducted. Various clinical outcomes, including all-cause...
  13. madman

    Dr. Khera highlights TRAVERSE trial of testosterone replacement therapy

    "So far, we have only 2 published, which is the cardiovascular results, which showed no increase in cardiovascular events, and the sexual function results, showing improvements in libido, but not erectile function, in up to 2 years," says Mohit Khera, MD, MBA, MPH...
  14. madman

    Navigating Erectile Dysfunction Together

    https://www.issm.info/meetings/issm-podcasts/issm-podcast-season-1-episode-21 In this episode, with Francesa Tripodi a sexologist, We delve into a pressing issue affecting many couples: Erectile Dysfunction (ED). We explore how ED, especially among men over 40, can strain relationships...
  15. madman

    Cardiovascular disease, osteoporosis and HRT

    This video features an interview with Professor Marco Gambacciani, a menopause specialist from Italy, discussing the importance of hormone replacement therapy (HRT) in reducing the risk of cardiovascular disease and osteoporosis in women. They highlight the lack of awareness and access to...
  16. madman

    Cardiovascular Safety of TRT

    https://www.sciencedirect.com/science/article/abs/pii/S0302283823031391?via%3Dihub Experts’ summary: Lincoff et al. conducted a multicenter, randomized, double-blind, placebo-controlled, noninferiority trial to evaluate the risk of cardiovascular and thromboembolic events with testosterone gel...
  17. madman

    Is ED an Independent Risk Factor or Risk Marker for CVD and What Is the Role of CT Calcium Scoring?

  18. madman

    Testosterone Replacement Therapy and CVD

    Abstract Purpose of Review The purpose of this review is to analyze the link between testosterone replacement therapy (TRT) and adverse cardiovascular (CV) events. Recent Findings A few published studies suggest a link between TRT and CV events. These studies contained flaws, and many...
  19. madman

    Are PDE-5 Inhibitors Cardioprotective?

  20. madman

    TRAVERSE: Cardiovascular Safety of TTh

    https://www.nejm.org/doi/10.1056/NEJMc2309389?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed https://www.nejm.org/doi/10.1056/NEJMc2309389?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed...
  21. madman

    Erectile Dysfunction and Cardiovascular Disease

  22. madman

    Testosterone and the heart

    ABSTRACT Cardiovascular disease (CVD) is the leading cause of death in women aged 65 years and older. Sex hormones have been implicated as having a critical role in the evolution of CVD, with the focus mainly on estrogens in women. Available data also indicate that low testosterone blood...
  23. madman

    The TRAVERSE trial: cardiovascular safety of TRT for older men

    Bradley D Anawalt University of Washington School of Medicine, Seattle, WA 98195, USA. For decades, there has been controversy about whether testosterone therapy has deleterious effects on the risk of major cardiovascular events in older men. As the number of prescriptions for testosterone...
  24. madman

    Importance of getting a calcium scan to assess the risk of heart disease

    In this video, Dr. Mark Scholz emphasizes the importance of getting a calcium scan to assess the risk of heart disease. He reveals that many prostate cancer patients face a higher risk of dying from heart-related problems rather than prostate cancer itself. The calcium scan is a simple and quick...
  25. madman

    Anabolic steroid use, brain health and dependence

    Anabolic steroid use has been found to have negative effects on brain health, cognitive function, and mental health, particularly in long-term users and those who develop dependence. Highlights Anabolic steroids can lead to smaller brain volumes, reduced cortical thickness, and structural...
  26. madman

    PDE5Is' growing role in men with diabetes and heart disease

    https://wchh.onlinelibrary.wiley.com/doi/full/10.1002/tre.926 PDE5 inhibitors can lower mortality and morbidity in men with type 2 diabetes and erectile dysfunction, but they are underused in this group. ED: An autonomous risk factor PDE5 inhibitors (PDE5Is) can reduce mortality and...
Back
Top